As organizations face talent shortages, shifting culture demands, generational transitions and heightened stakeholder ...
One of Cincinnati's most active developers will be doing something new when it builds a $40 million apartment project in ...
Eti-cel showed an 88% ORR and 63% CR (n=8) at current dose level in r/r NHL after ≥2 prior lines of therapyIn vivo data suggest IL-2 may further enhance response ...
Total consideration upon satisfaction of closing conditions will be approximately $4 million in ICG equity Up to US$5 million in additional ...
Strategically Located Within and Adjacent to Fresnillo Plc Concessions Dieppe, New Brunswick--(Newsfile Corp. - December 8, 2025) - Colibri ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company’s investigational RNA interference (RNAi) ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...